Neuronetics, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
STIM$2.01-7.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ Equity
(In thousands)
| | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Additional · Total | |||||||||||||||||
| · · Common Stock · · Paid-in · · Accumulated · · Noncontrolling · · Stockholders’ | |||||||||||||||||
| · Shares · Amount · Capital · Deficit · Interest · Equity | |||||||||||||||||
| Balance at December 31, 2021 | 26,395 | | $264 | | $393,644 | | $(308,733) | | $— | | $85,175 | ||||||
| Share-based awards and options exercises | 873 | | 9 | | 289 | | — | | — | | 298 | ||||||
| Share-based compensation expense | — | | — | | 8,746 | | — | | — | | 8,746 | ||||||
| Net loss | — | | — | | — | | (37,159) | | — | | (37,159) | ||||||
| Balance at December 31, 2022 | 27,268 | | 273 | | 402,679 | | (345,892) | | — | | 57,060 | ||||||
| Share-based awards and options exercises | 1,824 | | 18 | | (18) | | — | | — | | — | ||||||
| Share-based compensation expense | — | | — | | 7,319 | | — | | — | | 7,319 | ||||||
| Net loss | — | | — | | — | | (30,189) | | — | | (30,189) | ||||||
| Balance at December 31, 2023 | 29,092 | | 291 | | 409,980 | | (376,081) | | — | | 34,190 | ||||||
| Share-based awards and options exercises | 1,282 | | 13 | | (13) | | — | | — | | — | ||||||
| Issuance of warrants, net of issuance costs of $49 | | — | | | — | | | 2,521 | | | — | | | — | | | 2,521 |
| Issuance of stock as purchase consideration in connection with acquisition | | 25,305 | | | 253 | | | 28,848 | | | — | | | 4,112 | | | 33,213 |
| Share-based compensation expense | — | | — | | 5,602 | | — | | — | | 5,602 | ||||||
| Net loss | — | | — | | — | | (43,708) | | (19) | | (43,727) | ||||||
| Balance at December 31, 2024 | 55,679 | | $557 | | $446,938 | | $(419,789) | | $4,093 | | $31,799 | ||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.